FDA and CDC expand approval of updated Moderna and Pfizer-BioNTech COVID-19 booster vaccines for children Ages 5-17
Author

Blaire Bryant
Upcoming Events
Related News

Key Takeaways
On October 12, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 vaccines for children ages 5-17. Under the amended EUA, the Moderna vaccine is authorized for children ages 6 through 17 years of age, and the Pfizer vaccine is authorized for children five to 11 years of age.
Following FDA authorization, the Centers for Disease Control and Prevention (CDC), updated their COVID-19 vaccination recommendations to include the boosters for this younger age group.
Updated COVID-19 boosters add Omicron BA.4 and BA.5 variants to the current vaccine composition, helping to restore protection that has waned since previous vaccination and targeting recent Omicron strains that are more transmissible and immune compromising.
The approval of the updated COVID-19 boosters is a critical next step in the nation’s pandemic recovery efforts. County governments have been on the front lines of our nation’s vaccination efforts and will continue to work to coordinate distribution and administration of vaccines, which provide increased protection against severe COVID-19 disease and mortality.
ADDITIONAL RESOURCES
Resource
The County Role in Vaccines

Related News

NACo offers new Medicaid resources as Congress advances Budget Resolutions with major Medicaid reform implications
On April 10, the U.S. House of Representatives voted to adopt a Senate-passed budget resolution, marking the next step in the budget reconciliation process. The proposed funding levels therein represent significant potential cost shifts to counties, particularly in the area of Medicaid financing. To help county leaders understand what’s at stake, NACo has developed two new resources.

County Countdown – April 21, 2025
Every other week, NACo's County Countdown reviews top federal policy advocacy items with an eye towards counties and the intergovernmental partnership. This week features the ARPA reporting deadline, a budget reconciliation update and more

U.S. House reintroduces legislation to address the Medicaid Inmate Exclusion Policy
Two bipartisan bills aimed at addressing the Medicaid Inmate Exclusion Policy (MIEP) were recently reintroduced in the U.S. House of Representatives.